Prevention of neointima formation by mibefradil after vascular injury in rats: Comparison with ACE inhibition

Cardiovascular Drugs and Therapy

Volumn 10, Issue 2, 1996, Pages 101-105

  Schmitt, R ^a   Clozel, J P ^a   Iberg, N ^a   Buhler F R ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

ACE inhibition; Cilazapril; Hypertension; Mibefradil; Smooth muscle cells; Vascular injury

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MIBEFRADIL; NEW DRUG;

ANIMAL EXPERIMENT; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; HYPERTENSION; INTIMA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZIMIDAZOLES; CALCIUM CHANNEL BLOCKERS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CAROTID STENOSIS; CELL DIVISION; CELL MOVEMENT; CILAZAPRIL; HYPERTENSION; MALE; MIBEFRADIL; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM; TETRAHYDRONAPHTHALENES; TIME FACTORS; TUNICA INTIMA;

EID: 0029998414     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00823586     Document Type: Article

References (21)

1. Powell JS, Clozel JP, Müller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188.
2. Osterrieder W, Müller RKM, Powell JS, Clozel JP, Hefti F, Baumgartner HR. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension 1991;18: II60-II64.
3. MERCATOR, Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation 1992;86:100-110.
4. Clozel JP, Müller RKM, Roux S, Fischli W, Baumgartner HR. Influence of the status of the renin-angiotensin system on the effect of cilazapril on neointima formation after vascular injury in rats. Circulation 1993;88:1222-1227.
5. Fingerle J, Müller RKM, Kuhn H, Pech M, Baumgartner HR. Mechanism of inhibition of neointima formation by the angiotensin converting enzyme inhibitor cilazapril. Arterioscler Thromb Vasc Biol 1995;15:1945-1950.
6. Stary HC, Blankenhorn DH, Chandler AB, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. Arterioscler Thromb 1992;12:120-134.
7. Clowes AW, Reidy MA, Clowes MM. Kinetic of cellular proliferation after arterial injury. Lab Invest 1983;49: 327-334.
8. Epstein SE, Speir E, Unger EF, Guzman RJ, Finkle T. The basis of molecular strategies for treating coronary restenosis after angioplasty. J Am Coll Cardiol 1994;23: 1278-1288.
9. Block PC. Restenosis after percutaneous transluminal coronary angioplasty - Anatomic and pathophysiological mechanisms. Circulation 1990;81:IV2-IV4.
10. 2+ channel blocker with potent vasodilator but weak inotropic action. J Cardiovasc Pharmacol 1989;13:754-759.
11. Clozel JP, Osterrieder W, Kleinboesem CH, et al. Ro 40-5967: A new nondihydropyridine calcium antagonist. Cardiovasc Drug Rev 1991;9:4-17.
12. 2+ channels by Ro 40-5967. Circ Res 1994;75:144-18.
13. Schmitt R, Clozel JP, Iberg N, Bühler F. Mibefradil prevents neointima formation after vascular injury in rats: Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler Thromb, in press.
14. Carretero OA, Romero JC. Production and characteristics of experimental hypertension in animals. In: Genest J, Koiw E, Kuchel O, eds. Hypertension. New York: McGraw-Hill, 1977:485-506.
15. Oates HF, Stokes GS, Storey BG. Plasma renin concentration in hypertension produced by unilateral renal artery constriction in the rat. Clin Exp Pharmacol Physiol 1975; 2:289-296.
16. Natoff IL, Nixon JS, Francis RJ, et al. Biological properties of the angiotensin-converting enzyme inhibitor cilazapril. J Cardiovasc Pharmacol 1985;7:569-580.
17. Gerold M, Tschirky H. Measurement of blood pressure in unanesthetized rats and mice. Arzneim-Forsch/Drug Res 1969;18:1285-1287.
18. Haudenschild CC, Schwartz SM. Endothelial regeneration: II. Restitution of endothelial continuity. Lab Invest 1979; 41:407-418.
19. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68: 450-456.
20. Clozel JP, Hess P, Schietinger K, Breu V, Fischli W, Baumgartner HR. Major role of the renin angiotensin system in the neointima formation after vascular injury in guinea pigs. Life Sci 1994;54:PL87-92.
21. Schmitt R, Kleinboesem CH, Belz GG. Hemodynamic and humoral effects of the novel calicum antagonist Ro 40-5967 in patients with hypertension. Clin Pharmacol Ther 1992; 52:314-323.